tiprankstipranks
Trending News
More News >
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market

Huakang Biomedical Holdings Company Limited (8622) Revenue

Compare
0 Followers

Huakang Biomedical Holdings Company Limited Revenue

Huakang Biomedical Holdings Company Limited had a revenue of 6.16M in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 25.77M, Decreased 0.80%. In the fiscal year ending Dec 31, 2024, Huakang Biomedical Holdings Company Limited had annual revenue of 25.36M with 2.96% growth.
Revenue (ttm)
25.77M
Revenue Growth
2.54%
P/S Ratio
8.23
Revenue/Employee
HK$278,670
Employees
91
Market Cap
HK$208.77M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
25.36M730.00K+102.96%
Dec 31, 2023
24.63M-701.00K+97.23%
Dec 31, 2022
25.33M-797.00K+96.95%
Dec 31, 2021
26.13M4.16M+118.94%
Dec 31, 2020
21.97M-3.50M+86.24%
Dec 31, 2019
25.47M-3.21M+88.82%
Dec 31, 2018
28.68M2.14M+108.05%
Dec 31, 2017
26.54M1.13M+104.45%
Dec 31, 2016
25.41M